申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP0275482A2
公开(公告)日:1988-07-27
A novel prolinal derivative of general formula:
[wherein A represents a group of the general formula:
(wherein one of R1 and R2 represents hydrogen atom and the other represents alkyl group of from 2 to 5 carbon atoms, alkoxy group of from 1 to 5 carbon atom(s), phenyl group, benzyl group, cycloalkyl group of from 4 to 6 carbon atoms or (cycloalkyl group of from 4 to 6 carbon atoms) - methyl group or R1 and R2 each represents, same or different, alkyl group of from 1 to 4 carbon atom(s).) or a group of the general formula:
(wherein m represents an integer of from 3 to 6.)
n represents an integer of from 3 to 10.
D represents carbocyclic or heterocyclic ring unsubstituted or substituted by from one to three of halogen atom, nitro group, trifluoromethyl group, alkyl or alkoxy group of from 1 to 4 carbon atom(s).]
possess inhibitory activity on prolyl endopeptidase, and therefore be useful for treating and/or preventing agent for amnesia.
一种通式如下的新型普罗林纳衍生物
[其中 A 代表通式中的一个基团:
(其中R1和R2之一代表氢原子,另一个代表2至5个碳原子的烷基、1至5个碳原子的烷氧基、苯基、苄基、4至6个碳原子的环烷基或(4至6个碳原子的环烷基)-甲基或R1和R2各自代表相同或不同的1至4个碳原子的烷基)或通式如下的基团:
(其中 m 代表 3 至 6 的整数)。
n 代表 3 至 10 的整数。
D 代表未被取代或被 1 至 3 个卤素原子、硝基、三氟甲基、1 至 4 个碳原子的烷基或 烷氧基取代的碳环或杂环。
具有抑制脯氨酰内肽酶的活性,因此可用于治疗和/或预防健忘症。